当前位置:首页 - 行情中心 - 颖泰生物(920819) - 财务分析 - 资产负债表

颖泰生物

(920819)

  

流通市值:36.71亿  总市值:37.14亿
流通股本:12.12亿   总股本:12.26亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金937,424,499.121,020,979,931.881,144,662,654.681,018,052,897.72
  交易性金融资产---725,584.92
  应收票据及应收账款1,266,064,360.41,292,880,129.361,289,216,835.311,494,237,803.81
        应收账款1,266,064,360.41,292,880,129.361,289,216,835.311,494,237,803.81
  应收款项融资204,405,057.23160,683,740.7150,957,234.88118,289,036.62
  预付款项48,310,059.6850,709,500.3439,872,78761,231,201.42
  其他应收款合计86,146,373.3798,664,274.84138,415,540.3372,254,555.82
  其中:应收利息3,001,249.674,693,694.128,357,162.746,266,286.11
  存货1,364,620,872.441,214,187,045.011,334,641,060.081,335,150,954.94
  合同资产9,330,966.827,793,306.168,249,695.1815,206,998.72
  其他流动资产191,889,230.3186,871,048.41226,264,042.14239,007,351.22
  流动资产合计4,108,191,419.364,032,768,976.74,332,279,849.64,354,156,385.19
非流动资产:
  长期股权投资1,582,210,489.51,581,343,770.551,594,217,542.271,700,636,156.35
  投资性房地产108,013,272.23109,178,369.79110,343,467.43108,588,898.92
  固定资产3,294,839,249.973,387,355,531.673,475,688,820.593,042,171,583.71
  在建工程603,461,452.39582,049,236.89540,761,947.21905,206,815.96
  使用权资产30,169,308.5230,725,638.0931,281,967.6632,765,041.02
  无形资产657,697,156.4665,470,071.53672,416,280.88681,656,482.72
  商誉324,276,895.66324,276,895.66324,276,895.66374,366,777.39
  长期待摊费用16,832,046.4218,118,725.8119,310,540.520,480,412.42
  递延所得税资产210,413,527.91205,074,803.68201,534,031.94171,070,222.32
  其他非流动资产108,811,931.83107,376,328.0193,100,852.22104,544,478.87
  非流动资产合计6,936,725,330.837,010,969,371.687,062,932,346.367,141,486,869.68
  资产总计11,044,916,750.1911,043,738,348.3811,395,212,195.9611,495,643,254.87
流动负债:
  短期借款2,286,935,508.112,322,797,384.82,391,616,247.572,566,982,443.68
  交易性金融负债7,940,809.613,127,642.631,370.4-
  应付票据及应付账款1,498,819,136.081,437,337,451.981,558,120,610.351,306,166,670.33
  其中:应付票据726,637,714.64690,393,650.05837,490,931.97643,307,455.34
        应付账款772,181,421.44746,943,801.93720,629,678.38662,859,214.99
  预收款项4,413,612.164,682,006.994,716,628.67974,558.81
  合同负债42,741,403.4980,341,993.51124,143,138.6390,299,045.08
  应付职工薪酬58,261,626.8156,152,316.87112,315,290.1174,572,923.24
  应交税费24,027,351.4833,325,424.2947,345,707.6627,519,492.06
  其他应付款合计135,821,550.95132,292,125.01139,583,321.89119,866,649.09
  一年内到期的非流动负债1,105,140,171.981,118,375,982.011,191,238,423.02812,942,469.55
  其他流动负债2,879,051.465,642,969.547,684,389.916,828,948.48
  流动负债合计5,166,980,222.135,194,075,297.635,576,765,128.215,006,153,200.32
非流动负债:
  长期借款946,056,619.89907,960,731.86847,487,501.391,259,520,487.09
  租赁负债18,867,523.0622,965,730.7618,454,634.4716,958,107.1
  长期应付款4,669,771.754,691,611.754,668,901.754,692,391.75
  递延收益127,299,808.5129,874,737.46132,449,666.42114,600,478.35
  递延所得税负债46,322,720.5746,517,085.1146,661,560.3246,582,292.35
  非流动负债合计1,143,216,443.771,112,009,896.941,049,722,264.351,442,353,756.64
  负债合计6,310,196,665.96,306,085,194.576,626,487,392.566,448,506,956.96
所有者权益(或股东权益):
  实收资本(或股本)1,225,800,0001,225,800,0001,225,800,0001,225,800,000
  资本公积3,014,169,893.953,014,169,893.953,014,169,893.953,014,169,893.95
  其他综合收益-138,327,002.06-115,575,171.95-101,822,722.39-73,696,148.34
  专项储备13,945,784.9611,479,635.058,286,758.329,672,407.87
  盈余公积218,150,908.27218,150,908.27218,150,908.27218,150,908.27
  未分配利润425,686,066.32400,224,085.83419,970,824.71667,287,935.3
  归属于母公司股东权益合计4,759,425,651.444,754,249,351.154,784,555,662.865,061,384,997.05
  少数股东权益-24,705,567.15-16,596,197.34-15,830,859.46-14,248,699.14
  股东权益合计4,734,720,084.294,737,653,153.814,768,724,803.45,047,136,297.91
  负债和股东权益合计11,044,916,750.1911,043,738,348.3811,395,212,195.9611,495,643,254.87
公告日期2026-08-142026-04-242026-04-162025-10-24
审计意见(境内)标准无保留意见
TOP↑